(Q54495125)

English

Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/24302273

Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF. (English)

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/24302273

atrial fibrillation

0 references

0 references

peripheral artery disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Graeme J. Hankey

8

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/24302273

10

object named as

Robert M Califf

1 reference

Europe PubMed Central

30 May 2018

Kenneth W Mahaffey

9

object named as

Kenneth W Mahaffey

1 reference

Europe PubMed Central

30 May 2018

Jonathan P Piccini

4

object named as

Jonathan P Piccini

1 reference

Europe PubMed Central

30 May 2018

Jonathan L. Halperin

3

object named as

Jonathan Halperin

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/24302273

Günter Breithardt

5

object named as

Gunter Breithardt

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/24302273

Daniel E. Singer

6

object named as

Daniel E Singer

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/24302273

Anne S Hellkamp

2

object named as

Anne S Hellkamp

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/24302273

author name string

William Schuyler Jones

1

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/24302273

Keith A A Fox

7

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/24302273

Manesh R Patel

11

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/24302273

publication date

2 December 2013

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/24302273

European Heart Journal

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/24302273

35

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/24302273

242-249

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/24302273

4

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/24302273

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT492

21 January 2018

Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT492

21 January 2018

Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT492

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT492

21 January 2018

Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT492

21 January 2018

Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT492

21 January 2018

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT492

21 January 2018

Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT492

21 January 2018

Impact of vascular disease in predicting stroke and death in patients with atrial fibrillation: the Danish Diet, Cancer and Health cohort study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT492

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHT492

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/24302273

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/24302273

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54495125&oldid=2118218197"